Brownstein Hyatt Farber Schreck, LLP

Brownstein Hyatt Farber Schreck, LLP filed a Q2 report for Harmony Biosciences on July 20, 2026, reporting $50,000 in lobbying income.

Lobbying for Harmony Biosciences · Biopharmaceutical company

As filed: BROWNSTEIN HYATT FARBER SCHRECK, LLP for HARMONY BIOSCIENCES.

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

Pennsylvania

Lobbying activity 1

Issues related to the development and approval of therapies for rare diseases Pharmaceutical tariffs

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.